Hearing Loss Risks Associated With Tepezza
The approval of Tepezza® (teprotumumab) has been a major advancement in the treatment of thyroid eye disease (TED) (1). As the first FDA-approved medication specifically for TED, it has helped
January 1, 2026
English 
Spanish